Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Instil Bio Inc (NASDAQ:TIL)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Sep 15|
|Day's Range||16.25 - 19.7|
|52 Week Range||14.42 - 29.49|
Instil Bio Inc dividends
Instil Bio Inc has a market cap or net worth of $2.48 billion. The enterprise value is $0.
Instil Bio Inc has 128.76 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is -0.1256. Instil Bio Inc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.3759%. The beta is 0.0000, so Instil Bio Inc's price volatility has been lower than the market average.
In the last 12 months, Instil Bio Inc had revenue of $0 and earned $0 in profits. Earnings per share was $.
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer..